Analyst Price Target is $6.00
▲ +194.12% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Lannett in the last 3 months. The average price target is $6.00, with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 194.12% upside from the last price of $2.04.
Current Consensus is
The current consensus among 1 contributing investment analysts is to hold stock in Lannett. This Hold consensus rating has held steady for over two years.
Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.